Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults
about
Bone health in HIV and hepatitis B or C infectionsSafety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project.A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected AdultsHIV and Bone Complications: Understudied Populations and New Management Strategies.Emtricitabine + tenofovir alafenamide for the treatment of HIV.Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.The US Food and Drug Administration's tentative approval process and the global fight against HIV.Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
P2860
Q30238946-3EA9A56E-0879-4A0B-B35B-5523D63FA6AAQ33817410-C7ADCE9A-B41B-41E1-B1B3-473C3F62F359Q37582474-4E2C9B6F-1474-48CE-A28F-6DC566FA7164Q38978479-DFB6B89A-2B6C-4E79-BB25-448F491CBF31Q38984695-FB4534BB-A2CB-421A-9160-B7DC81370A55Q39002230-75B7C94A-4F84-4DBC-B15F-FA7EC9FD95ACQ39425755-58AC5D9D-D315-44BA-844D-B95C05B9E88FQ48019035-BD9A0350-E1A8-432A-B039-37BA2174871DQ50190669-7FCCBC78-1A58-4266-8776-BC4A2FB176FDQ54216584-19246FC8-0E6F-4C18-A671-573BE4604FC3Q54230654-FFBAB82F-18CE-4B1E-AEF4-0E178DAD5611
P2860
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brief Report: Efficacy and Saf ...... /Hepatitis B-Coinfected Adults
@en
Brief Report: Efficacy and Saf ...... Hepatitis B-Coinfected Adults.
@nl
type
label
Brief Report: Efficacy and Saf ...... /Hepatitis B-Coinfected Adults
@en
Brief Report: Efficacy and Saf ...... Hepatitis B-Coinfected Adults.
@nl
prefLabel
Brief Report: Efficacy and Saf ...... /Hepatitis B-Coinfected Adults
@en
Brief Report: Efficacy and Saf ...... Hepatitis B-Coinfected Adults.
@nl
P2093
P2860
P1476
Brief Report: Efficacy and Saf ...... /Hepatitis B-Coinfected Adults
@en
P2093
Andrew Cheng
Anthony Mills
Cynthia Brinson
GS-US-292-1249 Study Investigators
Gordon Crofoot
Jason Brunetta
Joel Gallant
Marshall Fordyce
Moupali Das
Paul Benson
P2860
P304
P356
10.1097/QAI.0000000000001069
P407
P577
2016-05-11T00:00:00Z